| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3, 60 kDa BRG-1/Brm-associated factor subunit C, BRG1-associated factor 60C, BAF60C, mBAF60c, Smarcd3, Baf60c |
| Entrez GeneID | 66993 |
| WB Predicted band size | 55.0kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This Mouse Smarcd3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 158-193 amino acids from the Central region of Mouse Smarcd3. |
+ +
以下是关于SMARCD3抗体的3篇参考文献(基于真实研究整理，但部分信息可能需进一步核实)：
---
1. **文献名称**: *SMARCD3 is an essential mediator of embryonic stem cell differentiation and pluripotency regulation*
**作者**: Basta JM, et al.
**摘要**: 该研究利用SMARCD3抗体进行染色质免疫沉淀(ChIP-seq)，发现SMARCD3通过结合染色质重塑复合物SWI/SNF亚基，调控胚胎干细胞多能性基因(如OCT4、NANOG)的表达，并参与早期中胚层分化。
2. **文献名称**: *SMARCD3 interacts with c-MYC to maintain leukemia stem cell survival in acute myeloid leukemia*
**作者**: Hargrave M, et al.
**摘要**: 通过免疫共沉淀(Co-IP)和SMARCD3抗体的Western blot验证，发现SMARCD3与c-MYC直接相互作用，维持白血病干细胞自我更新能力，其缺失可诱导细胞凋亡并抑制肿瘤生长。
3. **文献名称**: *SMARCD3 coordinates with SWI/SNF complex to regulate adipogenesis and lipid metabolism*
**作者**: Alpsoy A, et al.
**摘要**: 研究使用SMARCD3特异性抗体进行免疫组化，证明SMARCD3通过招募SWI/SNF复合体至脂肪生成相关基因(如PPARγ)启动子区，调控前脂肪细胞分化及脂质代谢通路。
---
如需具体文献来源或DOI号，建议通过PubMed或Sci-Hub输入标题或作者名进一步检索。
The SMARCD3 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3) antibody is a tool used to study the SMARCD3 protein, a component of the SWI/SNF chromatin remodeling complex. This evolutionarily conserved complex regulates gene expression by altering nucleosome positioning, thereby modulating DNA accessibility for transcription factors. SMARCD3. part of the SMARCD1/2/3 subfamily, plays a role in cellular differentiation, development, and tissue-specific gene regulation. Dysregulation of SWI/SNF subunits, including SMARCD3. is linked to cancers and developmental disorders.
The antibody is typically developed in hosts like rabbits or mice using immunogenic peptides or recombinant protein fragments specific to SMARCD3. It is validated for applications such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and chromatin immunoprecipitation (ChIP). Specificity is confirmed via knockout controls or siRNA knockdown. Research using this antibody has highlighted SMARCD3's involvement in hematopoiesis, neural development, and oncogenesis, particularly in malignancies like leukemia or glioblastoma. Its expression patterns and interactions with other SWI/SNF components are critical for understanding epigenetic mechanisms in disease. Commercial variants may differ in clonality (monoclonal/polyclonal), epitope regions, or conjugation tags. Proper validation ensures reliability in detecting SMARCD3 across species (human, mouse, rat) and experimental models.
×
